Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Taysha Gene Therapies Inc (NQ: TSHA ) 2.255 +0.005 (+0.22%) Streaming Delayed Price Updated: 11:53 AM EDT, Aug 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Taysha Gene Therapies Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Peeling Back The Layers: Exploring Taysha Gene Therapies Through Analyst Insights August 12, 2024 Via Benzinga TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Misses Revenue for Q2 2024 August 12, 2024 TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace Where Taysha Gene Therapies Stands With Analysts July 23, 2024 Via Benzinga Why Is Taysha Gene Therapies (TSHA) Stock Down 14% Today? June 26, 2024 Taysha Gene Therapies stock is down on Wednesday after the company announced a proposed public offering for TSHA shares. Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday June 26, 2024 It's time to dive into the biggest pre-market stock movers as we check out all of the latest news happening on Wednesday morning! Via InvestorPlace The Analyst Landscape: 16 Takes On Taysha Gene Therapies June 17, 2024 Via Benzinga Breaking Down Taysha Gene Therapies: 16 Analysts Share Their Views May 28, 2024 Via Benzinga 11 Analysts Assess Taysha Gene Therapies: What You Need To Know April 30, 2024 Via Benzinga Worthington Enterprises Posts Downbeat Results, Joins Taysha Gene Therapies, General Mills And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session June 26, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 19, 2024 Via Benzinga S&P 500 Edges Higher; America's Car-Mart Shares Tumble After Q4 Earnings June 18, 2024 Via Benzinga Topics Stocks Exposures US Equities Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 18, 2024 Via Benzinga Evaluating Taysha Gene Therapies: Insights From 7 Financial Analysts April 09, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session June 18, 2024 Via Benzinga Crude Oil Rises 1%; DermTech Shares Plummet June 18, 2024 Via Benzinga Exposures Fossil Fuels What's Going On With Taysha Gene Therapies Stock Tuesday? June 18, 2024 Taysha Gene Therapies reveals promising longer-term and initial clinical data from their REVEAL Phase 1/2 trials evaluating TSHA-102 for Rett syndrome. Via Benzinga TSHA Stock Earnings: Taysha Gene Therapies Beats EPS, Beats Revenue for Q1 2024 May 14, 2024 TSHA stock results show that Taysha Gene Therapies beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session April 12, 2024 U.S. stock futures were mixed this morning, with the Dow futures gaining over 50 points on Friday. Via Benzinga Topics Stocks Exposures US Equities Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday April 10, 2024 U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 09, 2024 Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free Via Benzinga BlackBerry, Nurix Therapeutics, Tesla And Other Big Stocks Moving Higher On Tuesday April 09, 2024 U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) rose sharply during Tuesday’s session. Via Benzinga Topics Stocks Exposures US Equities Spinal Delivery Of Taysha's Gene Therapy Shows Promise In Rare Childhood Neurodegenerative Disease March 21, 2024 Promising results from a Phase 1 trial led by NIH: scAAV9/JeT-GAN gene therapy shows potential benefits for giant axonal neuropathy. The therapy demonstrated safety and efficacy in children with GAN,... Via Benzinga Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday March 21, 2024 Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Via Benzinga Why Lifecore Biomedical Shares Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 20, 2024 Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) fell sharply during Wednesday’s session after the company announced it concluded its strategic evaluation process, announced management succession and... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session March 20, 2024 Via Benzinga Sportradar Group Posts Upbeat Earnings, Joins Kingsoft Cloud, Braskem And Other Big Stocks Moving Higher On Wednesday March 20, 2024 U.S. stocks were mixed, with the Dow Jones index gaining around 0.1% on Wednesday. Via Benzinga Topics Stocks Exposures US Equities Taysha Gene Therapies Shares Jump On Initial Data From First Pediatric Patient With Rare Neurodevelopmental Disorder March 20, 2024 Clinical data from Taysha Gene Therapies on TSHA-102, a potential gene therapy for Rett syndrome. Explore results in improved breathing, motor skills, and seizure management, paving the way for... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 20, 2024 Via Benzinga Why Taysha Gene Therapies Shares Are Trading Higher By Around 27%; Here Are 20 Stocks Moving Premarket March 20, 2024 Shares of Taysha Gene Therapies, Inc. (NASDAQ: TSHA) rose sharply in today’s pre-market trading after the company reported a year-over-year increase in FY23 EPS results. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday March 20, 2024 Pre-market stock movers are worth checking out as we dive into all of the biggest movements worth reading about on Wednesday morning! Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.